Town Health International Medical Group Limited (HKG:3886)
Hong Kong · Delayed Price · Currency is HKD 0.2550
+0.0050 (2.00%)
At close: Mar 27, 2026
HKG:3886 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,786 | 1,834 | 1,833 | 1,536 | 1,484 | |
Revenue Growth (YoY) | -2.63% | 0.04% | 19.37% | 3.48% | 38.80% |
Cost of Revenue | 1,321 | 1,346 | 1,331 | 1,121 | 1,013 |
Gross Profit | 464.15 | 487.39 | 501.95 | 414.45 | 471.26 |
Selling, General & Admin | 385.36 | 275.5 | 262.19 | 284.12 | 357.12 |
Amortization of Goodwill & Intangibles | - | 7.71 | 11.26 | 10.81 | - |
Operating Expenses | 385.36 | 396.76 | 396.2 | 397.96 | 357.12 |
Operating Income | 78.79 | 90.63 | 105.75 | 16.49 | 114.14 |
Interest Expense | -11.51 | -20.51 | -23.42 | -12.68 | -3.9 |
Interest & Investment Income | 33.91 | 34.24 | 33.25 | 30.82 | 17.61 |
Earnings From Equity Investments | 19.16 | -7.16 | -5.32 | -14.83 | 32.84 |
Other Non Operating Income (Expenses) | 7.45 | 3.17 | 11.61 | 6.06 | 3.06 |
EBT Excluding Unusual Items | 127.8 | 100.37 | 121.87 | 25.86 | 163.76 |
Impairment of Goodwill | -0.52 | -70 | -102.88 | -1.8 | -3.03 |
Gain (Loss) on Sale of Investments | -4.51 | -81.52 | -26.62 | -1.03 | -4.85 |
Gain (Loss) on Sale of Assets | 0.94 | -0.07 | 2.53 | 31.63 | -0.28 |
Asset Writedown | -18.71 | -70.47 | -115.76 | -5.95 | 35.93 |
Other Unusual Items | - | - | - | 33.8 | -65.02 |
Pretax Income | 105 | -121.69 | -120.86 | 82.5 | 126.51 |
Income Tax Expense | 40.2 | 36.52 | 38.23 | 32.98 | 51.44 |
Earnings From Continuing Operations | 64.8 | -158.21 | -159.09 | 49.52 | 75.07 |
Net Income to Company | 64.8 | -158.21 | -159.09 | 49.52 | 75.07 |
Minority Interest in Earnings | -50.42 | -45.5 | -35.12 | -34.23 | -53.06 |
Net Income | 14.38 | -203.7 | -194.21 | 15.29 | 22.01 |
Net Income to Common | 14.38 | -203.7 | -194.21 | 15.29 | 22.01 |
Net Income Growth | - | - | - | -30.55% | - |
Shares Outstanding (Basic) | 6,774 | 6,774 | 6,774 | 7,340 | 7,526 |
Shares Outstanding (Diluted) | 6,774 | 6,774 | 6,774 | 7,340 | 7,526 |
Shares Change (YoY) | - | -0.01% | -7.72% | -2.47% | - |
EPS (Basic) | 0.00 | -0.03 | -0.03 | 0.00 | 0.00 |
EPS (Diluted) | 0.00 | -0.03 | -0.03 | 0.00 | 0.00 |
EPS Growth | - | - | - | -28.80% | - |
Free Cash Flow | - | 206.11 | 229.79 | 5.82 | 151.01 |
Free Cash Flow Per Share | - | 0.03 | 0.03 | 0.00 | 0.02 |
Dividend Per Share | 0.002 | 0.001 | 0.001 | 0.001 | 0.002 |
Dividend Growth | 50.00% | - | - | -20.00% | - |
Gross Margin | 26.00% | 26.58% | 27.38% | 26.99% | 31.76% |
Operating Margin | 4.41% | 4.94% | 5.77% | 1.07% | 7.69% |
Profit Margin | 0.80% | -11.11% | -10.60% | 1.00% | 1.48% |
Free Cash Flow Margin | - | 11.24% | 12.54% | 0.38% | 10.18% |
EBITDA | 143.49 | 155.32 | 175.81 | 79.26 | 167.48 |
EBITDA Margin | 8.04% | 8.47% | 9.59% | 5.16% | 11.29% |
D&A For EBITDA | 64.7 | 64.7 | 70.06 | 62.77 | 53.34 |
EBIT | 78.79 | 90.63 | 105.75 | 16.49 | 114.14 |
EBIT Margin | 4.41% | 4.94% | 5.77% | 1.07% | 7.69% |
Effective Tax Rate | 38.29% | - | - | 39.98% | 40.66% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.